John Higuchi
Patrimonio netto: 458 543 $ in data 31/05/2026
Patrimonio netto: 458 543 $ in data 31/05/2026
John W.
Higuchi is the founder of Spriaso LLC.
Mr. Higuchi is an Independent Director at Lipocine, Inc. since 2003.
Mr. Higuchi was Chief Executive Officer at Aciont, Inc. from 2003 to 2022.
Mr. Higuchi completed graduate and MBAistration degrees at George Washington University and an undergraduate degree at Hope College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIPOCINE INC 2,47% | 03/06/2026 | 203.797 ( 2,47% ) | 458 543 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LIPOCINE INC. | Direttore/Membro del Consiglio | 01/01/2003 |
Spriaso LLC
Spriaso LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Fondatore | - |
| Società | Posizione | Fine |
|---|---|---|
Aciont, Inc.
Aciont, Inc. Medical DistributorsDistribution Services Engages in commercializing of localized, non-invasive, controlled and sustained release back of the eye therapeutics | Amministratore Delegato | 01/01/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hope College
Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipocine, Inc.
Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
Aciont, Inc.
Aciont, Inc. Medical DistributorsDistribution Services Engages in commercializing of localized, non-invasive, controlled and sustained release back of the eye therapeutics | Distribution Services |
Spriaso LLC
Spriaso LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale